1-20 of 21
Eva M. Schmelz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 80: Integrin driven adhesion in ovarian cancer

Nazia Bano, Isabelle Lewis, Malaika Amin, Eva M. Schmelz
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 80.
https://doi.org/10.1158/1538-7445.AM2025-80
Published: 21 April 2025
View articletitled, Abstract 80: Integrin driven adhesion in ovarian cancer
Journal Articles

Abstract 3077: Integrin expression during ovarian cancer progression

Nazia Bano, Eva M. Schmelz
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3077.
https://doi.org/10.1158/1538-7445.AM2024-3077
Published: 22 March 2024
View articletitled, Abstract 3077: Integrin expression during ovarian cancer progression
Journal Articles

Abstract 1687: Cyto R1 Platform enriches samples’ viability for single-cell sequencing and downstream assays

Alexandra R. Hyler, Alicia M. Cole, Ridi Barua, Amiran K. Dzutsev, Eva M. Schmelz
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1687.
https://doi.org/10.1158/1538-7445.AM2022-1687
Published: 15 June 2022
View articletitled, Abstract 1687: Cyto R1 Platform enriches samples’ viability for single-cell sequencing and downstream assays
Journal Articles

Abstract 2405: Metabolic plasticity of ovarian metastases in response to adherence and physiologically relevant culture conditions

Stephanie Edwards Compton, Joseph Grieco, Eva M. Schmelz
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2405.
https://doi.org/10.1158/1538-7445.AM2021-2405
Published: 01 July 2021
View articletitled, Abstract 2405: Metabolic plasticity of ovarian metastases in response to adherence and physiologically relevant culture conditions
Journal Articles

Abstract 5365: Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo

Mijal Munster, Christopher P. Roberts, Eva M. Schmelz, Moshe Giladi, Roni Blat, Rosa S. Schneiderman, Yaara Porat, Zeev Bomzon, Noa Urman, Aviran Itzhaki, Tali Voloshin Sela, Shay Cahal, Eilon D. Kirson, Uri Weinberg, Yoram Palti
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 5365.
https://doi.org/10.1158/1538-7445.AM2015-5365
Published: 01 August 2015
View articletitled, Abstract 5365: Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo
Journal Articles

Abstract LB-155: Ovarian cancer-induced changes in the intestinal microbiota as potential biomarkers for early detection

Eva M. Schmelz, Paul C. Roberts, Monica A. Ponder
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): LB-155.
https://doi.org/10.1158/1538-7445.AM2014-LB-155
Published: 01 October 2014
View articletitled, Abstract LB-155: Ovarian cancer-induced changes in the intestinal microbiota as potential biomarkers for early detection
Journal Articles

Abstract 401: Early immune modulatory events during ovarian cancer outgrowth in the omental fat band

Courtney A. Cohen, Amanda A. Shea, Eva M. Schmelz, Paul C. Roberts
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 401.
https://doi.org/10.1158/1538-7445.AM2012-401
Published: 15 April 2012
View articletitled, Abstract 401: Early immune modulatory events during ovarian cancer outgrowth in the omental fat band
Journal Articles

Abstract 1496: Changes in white adipose tissue progenitor populations with ovarian cancer

Amanda A. Shea, Courtney A. Cohen, Paul C. Roberts, Eva M. Schmelz
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1496.
https://doi.org/10.1158/1538-7445.AM2012-1496
Published: 15 April 2012
View articletitled, Abstract 1496: Changes in white adipose tissue progenitor populations with ovarian cancer
Journal Articles

Abstract 986: Metabolic changes in ovarian cancer progression and mediation by sphingosine: The MOSE model

Angela S. Anderson, Matthew W. Hulver, Tim Brown, Madlyn I. Frisard, Paul C. Roberts, Eva M. Schmelz
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 986.
https://doi.org/10.1158/1538-7445.AM2011-986
Published: 15 April 2011
View articletitled, Abstract 986: Metabolic changes in ovarian cancer progression and mediation by sphingosine: The MOSE model
Journal Articles

Abstract 2359: Regulation of cytoskeleton organization by sphingosine in a mouse cell model of ovarian cancer progression

Amy L. Creekmore, Eva M. Schmelz, P. C. Roberts
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2359.
https://doi.org/10.1158/1538-7445.AM2011-2359
Published: 15 April 2011
View articletitled, Abstract 2359: Regulation of cytoskeleton organization by sphingosine in a mouse cell model of ovarian cancer progression
Journal Articles

Abstract 5684: B-catenin-dependent and independent changes in gene expression induced by sphingolipids

Hui Zhou, Eva M. Schmelz
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 5684.
https://doi.org/10.1158/1538-7445.AM10-5684
Published: 15 April 2010
View articletitled, Abstract 5684: B-catenin-dependent and independent changes in gene expression induced by sphingolipids
Journal Articles

Abstract 2875: Regulation of gene expression by sphingosine in a mouse cell model of ovarian cancer progression

Amy L. Creekmore, Eva M. Schmelz, P. C. Roberts
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2875.
https://doi.org/10.1158/1538-7445.AM10-2875
Published: 15 April 2010
View articletitled, Abstract 2875: Regulation of gene expression by sphingosine in a mouse cell model of ovarian cancer progression
Journal Articles

Regression of Early and Intermediate Stages of Colon Cancer by Targeting Multiple Members of the EGFR Family with EGFR-Related Protein

Eva M. Schmelz, Hu Xu, Radha Sengupta, Jianhua Du, Sanjeev Banerjee, Fazlul H. Sarkar, Arun K. Rishi, Adhip P.N. Majumdar
Journal: Cancer Research
Cancer Res (2007) 67 (11): 5389–5396.
https://doi.org/10.1158/0008-5472.CAN-07-0536
Published: 01 June 2007
View articletitled, Regression of Early and Intermediate Stages of Colon Cancer by Targeting Multiple Members of the EGFR Family with EGFR-Related Protein
Open the PDF for Regression of Early and Intermediate Stages of Colon Cancer by Targeting Multiple Members of the EGFR Family with EGFR-Related Protein in another window
Journal Articles

Reversal of early stages of colorectal cancer with EGF-receptor related protein (ERRP)

Eva M. Schmelz, Hu Xu, Arun K. Rishi, Fazlul H. Sarkar, Adhip P. Majumdar
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 293.
Published: 15 April 2006
View articletitled, Reversal of early stages of colorectal cancer with EGF-receptor related protein (ERRP)
Journal Articles

Effects of sphingosine and Enigmol on mouse ovarian surface epithelial cells representing early, intermediate and late stages of ovarian cancer

Eva M. Schmelz, Andrea C. Baxa, Nicole Doyon-Reale, Paul C. Roberts
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 748–749.
Published: 15 April 2006
View articletitled, Effects of sphingosine and Enigmol on mouse ovarian surface epithelial cells representing early, intermediate and late stages of ovarian cancer
Journal Articles

Epigenetics in mouse model for progressive ovarian cancer

Paul C. Roberts, Emilio Mottillo, Andrea Baxa, Nicole Reale, Eva M. Schmelz
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1432.
Published: 01 May 2005
View articletitled, Epigenetics in mouse model for progressive ovarian cancer
Journal Articles

Reversal of aberrant β-catenin expression as possible mechanism for tumor prevention by orally administered sphingolipids

Eva M. Schmelz, Kirk W. Simon, Paul C. Roberts
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 820.
Published: 01 May 2005
View articletitled, Reversal of aberrant β-catenin expression as possible mechanism for tumor prevention by orally administered sphingolipids
Journal Articles

In vivo targets of dietary sphingolipids

Eva M. Schmelz, Michael J. Vespremi, Kirk W. Simon, Paul C. Roberts
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 315.
Published: 01 April 2004
View articletitled, In vivo targets of dietary sphingolipids
Journal Articles

Modulation of Intracellular β-Catenin Localization and Intestinal Tumorigenesis in Vivo and in Vitro by Sphingolipids

Eva M. Schmelz, Paul C. Roberts, Elizabeth M. Kustin, Lori A. Lemonnier, M. Cameron Sullards, Dirck L. Dillehay, Alfred H. Merrill, Jr.
Journal: Cancer Research
Cancer Res (2001) 61 (18): 6723–6729.
Published: 01 September 2001
View articletitled, Modulation of Intracellular β-Catenin Localization and Intestinal Tumorigenesis in Vivo and in Vitro by Sphingolipids
Open the PDF for Modulation of Intracellular β-Catenin Localization and Intestinal Tumorigenesis in Vivo and in Vitro by Sphingolipids in another window
Journal Articles

Ceramide-β-d-Glucuronide: Synthesis, Digestion, and Suppression of Early Markers of Colon Carcinogenesis1

Eva M. Schmelz, Anatoliy S. Bushnev, Dirck L. Dillehay, M. Cameron Sullards, Dennis C. Liotta, Alfred H. Merrill, Jr.
Journal: Cancer Research
Cancer Res (1999) 59 (22): 5768–5772.
Published: 01 November 1999
View articletitled, Ceramide-β-d-Glucuronide: Synthesis, Digestion, and Suppression of Early Markers of Colon Carcinogenesis1
Open the PDF for Ceramide-β-d-Glucuronide: Synthesis, Digestion, and Suppression of Early Markers of Colon Carcinogenesis1 in another window